Literature DB >> 31431709

Immune regulation in hematopoietic cell transplantation.

Robert S Negrin1.   

Abstract

Immune regulation is critically important in health and disease. These immune effects have direct relevance in the setting of allogeneic hematopoietic cell transplantation (HCT), principally for the control of aberrant immune reactions, such as graft-versus-host disease (GVHD). Murine models have been critically important to evaluate the potential of two of the most potent immune regulatory cells CD4+CD25+FoxP+ regulatory T cells (Treg) and invariant natural killer T cells (iNKT cells). These cells have been shown to be remarkably effective in murine models to control GVHD and allow for the maintenance of graft-versus-tumor (GVT) effects. Interestingly, there are critical interactions between these different cell populations. Future studies are aimed at exploring the biology of these important regulatory cells and to translate these concepts to the clinic that holds promise for controlling some of the major challenges of allogeneic HCT.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31431709     DOI: 10.1038/s41409-019-0600-7

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival.

Authors:  Florent Malard; Myriam Labopin; Patrice Chevallier; Thierry Guillaume; Alix Duquesne; Fanny Rialland; Sophie Derenne; Pierre Peterlin; Anne-Gaelle Leauté; Eolia Brissot; Marc Gregoire; Philippe Moreau; Philippe Saas; Béatrice Gaugler; Mohamad Mohty
Journal:  Blood       Date:  2016-02-22       Impact factor: 22.113

2.  Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.

Authors:  Byung-Su Kim; Hidekazu Nishikii; Jeanette Baker; Antonio Pierini; Dominik Schneidawind; Yuqiong Pan; Andreas Beilhack; Chung-Gyu Park; Robert S Negrin
Journal:  Blood       Date:  2015-06-10       Impact factor: 22.113

3.  Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Authors:  M-T Rubio; M Bouillié; N Bouazza; T Coman; H Trebeden-Nègre; A Gomez; F Suarez; D Sibon; A Brignier; E Paubelle; S Nguyen-Khoc; M Cavazzana; O Lantz; M Mohty; S Urien; O Hermine
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

4.  [Effect of Arzni Health Resort factors on external respiratory circulatory function in hypertension].

Authors:  V G Amatunian; E A Oganova
Journal:  Vopr Kurortol Fizioter Lech Fiz Kult       Date:  1973

5.  [Bilirubin concentration of amniotic fluid in Rh incompatibility].

Authors:  B Reil; G Schellong; H Mast
Journal:  Dtsch Med Wochenschr       Date:  1969-12-12       Impact factor: 0.628

6.  DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.

Authors:  Hidekazu Nishikii; Byung-Su Kim; Yasuhisa Yokoyama; Yan Chen; Jeanette Baker; Antonio Pierini; Maite Alvarez; Melissa Mavers; Kristina Maas-Bauer; Yuqiong Pan; Shigeru Chiba; Robert S Negrin
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

7.  Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

Authors:  Dominik Schneidawind; Jeanette Baker; Antonio Pierini; Corina Buechele; Richard H Luong; Everett H Meyer; Robert S Negrin
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

8.  A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.

Authors:  John A Ronald; Byung-Su Kim; Gayatri Gowrishankar; Mohammad Namavari; Israt S Alam; Aloma D'Souza; Hidekazu Nishikii; Hui-Yen Chuang; Ohad Ilovich; Chih-Feng Lin; Robert Reeves; Adam Shuhendler; Aileen Hoehne; Carmel T Chan; Jeanette Baker; Shahriar S Yaghoubi; Henry F VanBrocklin; Randall Hawkins; Benjamin L Franc; Salma Jivan; James B Slater; Emily F Verdin; Kenneth T Gao; Jonathan Benjamin; Robert Negrin; Sanjiv Sam Gambhir
Journal:  Cancer Res       Date:  2017-06-01       Impact factor: 12.701

9.  Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.

Authors:  Jing Du; Katelyn Paz; Govindarajan Thangavelu; Dominik Schneidawind; Jeanette Baker; Ryan Flynn; Omar Duramad; Colby Feser; Angela Panoskaltsis-Mortari; Robert S Negrin; Bruce R Blazar
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

  9 in total
  4 in total

Review 1.  Harnessing invariant natural killer T cells to control pathological inflammation.

Authors:  Nikhila S Bharadwaj; Jenny E Gumperz
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

2.  iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.

Authors:  Nicholas J Hess; Nikhila S Bharadwaj; Elizabeth A Bobeck; Courtney E McDougal; Shidong Ma; John-Demian Sauer; Amy W Hudson; Jenny E Gumperz
Journal:  Life Sci Alliance       Date:  2021-06-10

3.  Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD.

Authors:  Toshihito Hirai; Po-Yu Lin; Federico Simonetta; Kristina Maas-Bauer; Mustafa Turkoz; Melissa Mavers; Jeanette Baker; Robert S Negrin
Journal:  Blood Adv       Date:  2021-06-08

Review 4.  How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Benoît Vandenhove; Lorenzo Canti; Hélène Schoemans; Yves Beguin; Frédéric Baron; Carlos Graux; Tessa Kerre; Sophie Servais
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.